BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Das G, Das T, Chowdhury N, Chatterjee D, Bagchi A, Ghosh Z. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19. Genomics 2021;113:1129-40. [PMID: 33189776 DOI: 10.1016/j.ygeno.2020.11.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Atoum MF, Padma KR, Don KR. Paving New Roads Using Allium sativum as a Repurposed Drug and Analyzing its Antiviral Action Using Artificial Intelligence Technology. Iran J Pharm Res 2022;21:e131577. [PMID: 36915406 DOI: 10.5812/ijpr-131577] [Reference Citation Analysis]
2 Zhou Y, Wang H, Yang L, Wang Q. Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology. Molecules 2022;27. [PMID: 36500347 DOI: 10.3390/molecules27238257] [Reference Citation Analysis]
3 Yang R, Wu S, Wang S, Rubino G, Nickels JD, Cheng X. Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations. Front Mol Biosci 2022;9:1027223. [DOI: 10.3389/fmolb.2022.1027223] [Reference Citation Analysis]
4 Tian L, Liu Q, Pei R, Chen Y, Xu C, Tang J, Sun H, Liu K, Yang Q, Yang L, Li L, Zhang Y, Zhou Y, Shan C, Hu X, Chen X, Wang Y. Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release. Virol Sin 2022:S1995-820X(22)00114-6. [PMID: 35781091 DOI: 10.1016/j.virs.2022.06.008] [Reference Citation Analysis]
5 Debnath SK, Debnath M, Srivastava R, Omri A. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability. Expert Rev Anti Infect Ther 2022. [PMID: 35615888 DOI: 10.1080/14787210.2022.2082944] [Reference Citation Analysis]
6 Khataniar A, Pathak U, Rajkhowa S, Jha AN. A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19. COVID 2022;2:148-67. [DOI: 10.3390/covid2020011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
7 Subhaswaraj P, Siddhardha B. Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection 2022. [DOI: 10.1016/b978-0-323-91172-6.00007-8] [Reference Citation Analysis]
8 Pires C. A Systematic Review on the Contribution of Artificial Intelligence in the Development of Medicines for COVID-2019. J Pers Med 2021;11:926. [PMID: 34575703 DOI: 10.3390/jpm11090926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Wang H, Zhang J, Lu Z, Dai W, Ma C, Xiang Y, Zhang Y. Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients. Brief Bioinform 2021:bbab373. [PMID: 34505138 DOI: 10.1093/bib/bbab373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Lee KLK, Patterson J, Burkhardt AM, Vankayalapati V, Mccarthy MC, Mcguire BA. Machine Learning of Interstellar Chemical Inventories. ApJL 2021;917:L6. [DOI: 10.3847/2041-8213/ac194b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Trobec T. The role of the SARS-CoV-2 envelope protein as a pH-dependent cation channel. J Physiol 2021;599:3435-6. [PMID: 34089533 DOI: 10.1113/JP281785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Savant S, Srinivasan S, Kruthiventi AK. Potential Nutraceuticals for COVID-19. NDS 2021;Volume 13:25-51. [DOI: 10.2147/nds.s294231] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]